Senior analyst Jennifer Fritzsche points out the company's diversified revenue base and calls the shares relatively cheap.
Shares of online gaming developer and provider Zynga get a boost after an analyst at Wedbush Securities adds the company to the firm's 'best ideas' list.
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
Amgen is finally making an expected splash out of its cash pile, but questions are abounding about the cost paid for Celgene's Otezla.
Salesforce is characteristically sustaining strength despite a heap of headwinds.
Analyst Rohit Kulkarni initiates the San Francisco parent of the collaboration app at buy with a $40 price target, indicating 30% upside potential from Wednesday's close.
Solar-energy-tech provider's shares drop amid UBS stock downgrade and news that the founder and CEO has taken a leave of absence for a health issue.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.